Institutional investors control 10.21% of the outstanding shares in AZN. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended March 2016, these large investors purchased a net $35.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DODGE & COX Bought 14.3 Million shares of AstraZeneca
PRIMECAP MANAGEMENT CO. Bought 12.1 Million shares of AstraZeneca
ARROWSTREET CAPITAL LP Bought 3.0 Million shares of AstraZeneca